REGISTERED NUMBER: 13471461 (England and Wales)

Unaudited Financial Statements for the Year Ended 30th June 2025

for

ChangeMed Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Ms J Flynn

Professor D J Wright

REGISTERED OFFICE:

Canal Cottage

Leek Road

Sutton

Macclesfield

Cheshire

SK11 0JF

REGISTERED NUMBER:

13471461 (England and Wales)

ACCOUNTANTS:

Dunkley's

Woodlands Grange

Woodlands Lane

Bradley Stoke

Bristol

United Kingdom

BS32 4JY

FIXED ASSETS

Intangible assets

4

5,502

6,197

Tangible assets

5

455

-

5,957

6,197

CURRENT ASSETS

Debtors

6

1,370

1,026

Cash at bank

4,508

11,444

5,878

12,470

CREDITORS

Amounts falling due within one year

7

5,341

5,217

NET CURRENT ASSETS

537

7,253

TOTAL ASSETS LESS CURRENT LIABILITIES

6,494

13,450

PROVISIONS FOR LIABILITIES

86

-

NET ASSETS

6,408

13,450

CAPITAL AND RESERVES

Called up share capital

8

2

2

Retained earnings

9

6,406

13,448

SHAREHOLDERS' FUNDS

6,408

13,450

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13th January 2026 and were signed on its behalf by:

Ms J Flynn - Director

1.	STATUTORY INFORMATION

ChangeMed Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

£

COST

At 1st July 2024

and 30th June 2025

6,950

AMORTISATION

At 1st July 2024

753

Charge for year

695

At 30th June 2025

1,448

NET BOOK VALUE

At 30th June 2025

5,502

At 30th June 2024

6,197

5.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

Additions

465

At 30th June 2025

465

DEPRECIATION

Charge for year

10

At 30th June 2025

10

NET BOOK VALUE

At 30th June 2025

455

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.6.25

30.6.24

£

£

Trade debtors

-

925

Amounts owed by group undertakings

101

101

Tax

1,269

-

1,370

1,026

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.6.25

30.6.24

£

£

Tax

-

1,250

Directors' current accounts

1,751

706

Deferred income

1,875

1,875

Accrued expenses

1,715

1,386

5,341

5,217

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.6.25

30.6.24

value:

£

£

2

Ordinary

£1

2

2

9.

RESERVES

Retained

earnings

£

At 1st July 2024

13,448

Deficit for the year

(6,042

)

Dividends

(1,000

)

At 30th June 2025

6,406

10.	RELATED PARTY DISCLOSURES

As at 30 June 2025, ChangeMed Limited was owed £101 (2024: £101), by a company with a director/shareholder in common.

This loan was interest free, repayable on demand and not secured against any assets.